AI-generated summary
The authors compared nonpurpuragenic pulsed dye laser with intense pulsed light in a randomized, single-blind, split-face trial of 29 patients with moderate erythematotelangiectatic rosacea. Both treatments were associated with reduced erythema, telangiectasia and patient-reported symptoms, with no significant difference between them. The authors concluded both are reasonable options.
- Participants
- 29
- Who or what was studied
- Patients with moderate facial erythematotelangiectatic rosacea
- Wavelengths
- 560 nm
- Limits stated in the abstract
- The abstract reports a single-blind design with a small sample of 29 patients and does not describe long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.